Diversified Trust Co Purchases 1,311 Shares of Bath & Body Works, Inc. $BBWI

Diversified Trust Co lifted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 9.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 14,620 shares of the company’s stock after acquiring an additional 1,311 shares during the quarter. Diversified Trust Co’s holdings in Bath & Body Works were worth $438,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. SVB Wealth LLC bought a new position in shares of Bath & Body Works during the 1st quarter worth $35,000. Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC lifted its holdings in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Golden State Wealth Management LLC lifted its holdings in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after purchasing an additional 642 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company’s stock worth $46,000 after purchasing an additional 596 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

BBWI opened at $26.60 on Wednesday. The stock’s 50 day simple moving average is $29.37 and its 200 day simple moving average is $29.67. Bath & Body Works, Inc. has a 1 year low of $24.93 and a 1 year high of $41.87. The firm has a market cap of $5.48 billion, a price-to-earnings ratio of 7.89, a PEG ratio of 0.89 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the company earned $0.37 EPS. Bath & Body Works’s revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.0%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 23.74%.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of recent research reports. Telsey Advisory Group reissued an “outperform” rating and set a $38.00 price objective on shares of Bath & Body Works in a report on Thursday, August 28th. Wall Street Zen cut Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. JPMorgan Chase & Co. increased their price objective on Bath & Body Works from $40.00 to $46.00 and gave the stock an “overweight” rating in a report on Monday, July 28th. Morgan Stanley dropped their price objective on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a report on Friday, September 12th. Finally, UBS Group dropped their price objective on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $39.69.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.